The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models
- 31 March 1991
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 8 (2), 79-94
- https://doi.org/10.1016/0920-1211(91)90075-q
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Amygdala-kindling as a model for chronic efficacy studies on antiepileptic drugs: Experiments with carbamazepineNeuropharmacology, 1989
- Tolerance to the anticonvulsant effect of benzodiazepinesTrends in Pharmacological Sciences, 1988
- Diazepam and desmethyldiazepam differ in their affinities and efficacies at ‘central’ and ‘peripheral’ benzodiazepine receptorsJournal of Pharmacy and Pharmacology, 1987
- Variation in threshold and pattern of electroshock-induced seizures in rats depending on site of stimulationLife Sciences, 1985
- Effect of GABA agonists on the neurotoxicity and anticonvulsant activity of benzodiazepinesLife Sciences, 1985
- Primdone, phenobarbital, and PEMANeurology, 1983
- Micromolar Affinity Benzodiazepine Receptors: Identification and Characterization in Central Nervous SystemScience, 1982
- Antiepileptic Drug Development: II. Anticonvulsant Drug ScreeningEpilepsia, 1978
- Acute tolerance to diazepam in cats and its possible relationship to diazepam metabolismEuropean Journal of Pharmacology, 1971
- Blood Level Distribution Patterns of Diazepam and its Major Metabolite in ManJournal of Pharmaceutical Sciences, 1966